Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

[Immunotherapy with immune checkpoint inhibitors and hepatitis].

Baudoux N, Berthod G, Bally F, Renard P, Anchisi S.

Rev Med Suisse. 2019 May 15;15(651):1017-1021. French.

PMID:
31091035
2.

Influenza A Virus Genetic Tools: From Clinical Sample to Molecular Clone.

Anchisi S, Gonçalves AR, Mazel-Sanchez B, Cordey S, Schmolke M.

Methods Mol Biol. 2018;1836:33-58. doi: 10.1007/978-1-4939-8678-1_3.

PMID:
30151568
3.

Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.

Santa Cruz O, Tsoutsou P, Castella C, Khanfir K, Anchisi S, Bouayed S, Matzinger O, Ozsahin M.

Oncology. 2018;95(2):61-68. doi: 10.1159/000489217. Epub 2018 Jun 12.

PMID:
29895020
4.

[Oncology trajectories of elderly patients in a palliative situation : « The long and winding road »].

Anchisi A, Foley RA, Ansermet C, Anchisi S.

Rev Med Suisse. 2018 May 16;14(607):1042-1046. French.

PMID:
29767897
5.

[Hemolytic anemia in cancer].

Anastasiou M, Chalandon Y, Anchisi S.

Rev Med Suisse. 2018 May 16;14(607):1021-1027. French.

PMID:
29767893
6.

Molecular response to nitrogen starvation by Frankia alni ACN14a revealed by transcriptomics and functional analysis with a fosmid library in Escherichia coli.

Lurthy T, Alloisio N, Fournier P, Anchisi S, Ponsero A, Normand P, Pujic P, Boubakri H.

Res Microbiol. 2018 Feb - Mar;169(2):90-100. doi: 10.1016/j.resmic.2017.12.002. Epub 2018 Mar 2.

PMID:
29378337
7.

Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.

Asgari S, Schlapbach LJ, Anchisi S, Hammer C, Bartha I, Junier T, Mottet-Osman G, Posfay-Barbe KM, Longchamp D, Stocker M, Cordey S, Kaiser L, Riedel T, Kenna T, Long D, Schibler A, Telenti A, Tapparel C, McLaren PJ, Garcin D, Fellay J.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8342-8347. doi: 10.1073/pnas.1704259114. Epub 2017 Jul 17.

8.

[Diarrhea caused by systemic anti-cancer treatments].

Dischl-Antonioni I, Berthod G, Hiroz P, Anchisi S.

Rev Med Suisse. 2016 Sep 7;12(529):1462-1467. French.

PMID:
28675266
9.

Le patient au centre et l’interprofessionnalité : de l’injonction à la pratique.

Anchisi S, Hug MC.

Rev Med Suisse. 2016 Sep 7;12(529):1451. French. No abstract available.

PMID:
28675264
10.

[Renal toxicities in oncology therapies].

Rodrigues B, Anchisi S, Petignat PA, Gobin N.

Rev Med Suisse. 2017 May 17;13(563):1055-1058. Review. French.

PMID:
28636298
11.

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.

Rochlitz C, Bigler M, von Moos R, Bernhard J, Matter-Walstra K, Wicki A, Zaman K, Anchisi S, Küng M, Na KJ, Bärtschi D, Borner M, Rordorf T, Rauch D, Müller A, Ruhstaller T, Vetter M, Trojan A, Hasler-Strub U, Cathomas R, Winterhalder R; Swiss Group for Clinical Cancer Research (SAKK).

BMC Cancer. 2016 Oct 10;16(1):780.

12.

[Cancer as a chronic disease: what changes for our practice?].

Anchisi S.

Rev Med Suisse. 2016 Jan 27;12(503):167-8. French. No abstract available.

PMID:
26939165
13.

Mismatches in the Influenza A Virus RNA Panhandle Prevent Retinoic Acid-Inducible Gene I (RIG-I) Sensing by Impairing RNA/RIG-I Complex Formation.

Anchisi S, Guerra J, Mottet-Osman G, Garcin D.

J Virol. 2015 Oct 7;90(1):586-90. doi: 10.1128/JVI.01671-15. Print 2016 Jan 1.

14.

RIG-I ATPase activity and discrimination of self-RNA versus non-self-RNA.

Anchisi S, Guerra J, Garcin D.

MBio. 2015 Mar 3;6(2):e02349. doi: 10.1128/mBio.02349-14.

15.

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06).

Koeberle D, Betticher DC, von Moos R, Dietrich D, Brauchli P, Baertschi D, Matter K, Winterhalder R, Borner M, Anchisi S, Moosmann P, Kollar A, Saletti P, Roth A, Frueh M, Kueng M, Popescu RA, Schacher S, Hess V, Herrmann R.

Ann Oncol. 2015 Apr;26(4):709-14. doi: 10.1093/annonc/mdv011. Epub 2015 Jan 20.

PMID:
25605741
16.

[Pain and cancer: what are our means?].

Anchisi S.

Rev Med Suisse. 2014 Jan 29;10(415):288-9. French. No abstract available.

PMID:
24624694
17.

[Working together for better care].

Tschopp JM, Hug MC, Anchisi S.

Rev Med Suisse. 2013 Nov 13;9(406):2075-6. French. No abstract available.

PMID:
24383279
18.

Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.

Betticher DC, Delmore G, Breitenstein U, Anchisi S, Zimmerli-Schwab B, Müller A, von Moos R, Hügli-Dayer AM, Schefer H, Bodenmann S, Bühler V, Trueb RR.

Support Care Cancer. 2013 Sep;21(9):2565-73. doi: 10.1007/s00520-013-1804-9. Epub 2013 May 2.

PMID:
23636645
19.

[Advanced lung cancer: supportive care].

Anchisi S.

Rev Med Suisse. 2013 Jan 30;9(371):269-71. French. No abstract available.

PMID:
23451599
20.

[Differenciated thyroid cancer: management and indication of the new targeted therapies].

Krahenbuhl T, Portmann L, Anchisi S.

Rev Med Suisse. 2012 May 23;8(342):1112-7. Review. French.

PMID:
22734180
21.

Lectin genes in the Frankia alni genome.

Pujic P, Fournier P, Alloisio N, Hay AE, Maréchal J, Anchisi S, Normand P.

Arch Microbiol. 2012 Jan;194(1):47-56. doi: 10.1007/s00203-011-0770-1. Epub 2011 Dec 8.

PMID:
22159868
22.

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).

Pesce GA, Klingbiel D, Ribi K, Zouhair A, von Moos R, Schlaeppi M, Caspar CB, Fischer N, Anchisi S, Peters S, Cathomas R, Bernhard J, Kotrubczik NM, D'Addario G, Pilop C, Weber DC, Bodis S, Pless M, Mayer M, Stupp R.

Eur J Cancer. 2012 Feb;48(3):377-84. doi: 10.1016/j.ejca.2011.10.016. Epub 2011 Nov 15.

PMID:
22093943
23.

Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.

Khanfir K, Elhfidh M, Anchisi S, Matzinger O, Bieri S, Mirimanoff RO, Ozsahin M, Zouhair A.

Swiss Med Wkly. 2011 May 31;141:w13205. doi: 10.4414/smw.2011.13205. eCollection 2011.

24.

[Hepatocarcinoma: what does the physician need to know?].

Anchisi S.

Rev Med Suisse. 2011 Jan 26;7(279):228-9. French. No abstract available.

PMID:
21387726
25.

[Going through chemotherapy: an age-revealing process].

Anchisi S, Anchisi A.

Bull Cancer. 2008 May 28;95 FMC Onco:F44-50. doi: 10.1684/bdc.2007.0532. French.

PMID:
18511366
26.

[What is your diagnosis? Referred bilateral knee arthralgia, secondary to presacral postoperative effusion].

Mahitchi E, Anchisi S, Van Linthoudt D.

Praxis (Bern 1994). 2008 Aug 13;97(16):883-4. French. No abstract available.

PMID:
18777715
27.

Pemetrexed-associated radiation recall dermatitis.

Khanfir K, Anchisi S.

Acta Oncol. 2008;47(8):1607-8. doi: 10.1080/02841860802120036. No abstract available.

PMID:
18607836
28.

[Accepting chemotherapy at the age of 70 and over: between autonomy and ageing].

Anchisi A, Anchisi S, Hugentobler V, Luyet V, Pott M.

Bull Cancer. 2006 Apr;93(4):407-14. French.

29.

The effects of beta1-adrenergic blockade on cardiovascular oxygen flow in normoxic and hypoxic humans at exercise.

Ferretti G, Licker MJ, Anchisi S, Moia C, Susta D, Morel DR.

Eur J Appl Physiol. 2005 Oct;95(2-3):250-9. Epub 2005 Oct 1.

PMID:
16200423
30.

Energetics of walking in patients with peripheral arterial disease: a proposed functional evaluation protocol.

Marconi C, Ferretti G, Anchisi S, Catalano M, Scandale G, Antico A, Iob G, Peinetti F, Cerretelli P.

Clin Sci (Lond). 2003 Jul;105(1):105-11.

PMID:
12627999
31.

Oxygen delivery and oxygen return in humans exercising in acute normobaric hypoxia.

Anchisi S, Moia C, Ferretti G.

Pflugers Arch. 2001 Jun;442(3):443-50.

PMID:
11484777
32.

Infusional ECarboF in patients with advanced breast cancer: a very active and well-tolerated out-patient regimen.

Hügli A, Sappino AP, Anchisi S, Mermillod B, Schafer P, Anguenot JL, Bonnefoi H.

Ann Oncol. 2000 Dec;11(12):1557-61.

PMID:
11205463
33.

Mental neuropathy: report of five cases and review of the literature.

Laurencet FM, Anchisi S, Tullen E, Dietrich PY.

Crit Rev Oncol Hematol. 2000 Apr;34(1):71-9.

PMID:
10781749
34.

Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes.

Allal AS, Bieri S, Pelloni A, Spataro V, Anchisi S, Ambrosetti P, Sprangers MA, Kurtz JM, Gertsch P.

Br J Cancer. 2000 Mar;82(6):1131-7.

35.

Management of an isolated thymic mass after primary therapy for lymphoma.

Anchisi S, Abele R, Guetty-Alberto M, Alberto P.

Ann Oncol. 1998 Jan;9(1):95-100. Review. No abstract available.

PMID:
9541689
36.

[Treatment of aggressive non Hodgkin's lymphoma: the experience of a general hospital].

Laurencet FM, Zulian GB, Dietrich PY, Anchisi S, Mermillod B, Alberto P.

Bull Cancer. 1996 Oct;83(10):864-9. French.

PMID:
8952637
37.

Lymphoma of uncertain phenotype.

Zulian GB, Dietrich PY, Conne B, Anchisi S, Pache JC, Rouden C, Alberto P.

Ann Oncol. 1995 Oct;6(8):827-32. No abstract available.

PMID:
8589022
38.

Cladribine and tumour lysis syndrome.

Anchisi S, Zulian GB, Dietrich PY, Alberto P.

Eur J Cancer. 1995;31A(1):131-2. No abstract available.

PMID:
7695970
39.

Uncommon origin for the iliopsoas sign.

Balagué F, Anchisi S, Schumacher JD, Hoogewoud HM, Waldburger M.

J Rheumatol. 1993 Mar;20(3):510-1.

PMID:
8478860
40.

[Primary Hodgkin disease of the lung].

Anchisi S, Pugin P, Baur A.

Schweiz Med Wochenschr. 1993 Jan 23;123(3):65-6. French.

PMID:
7678941

Supplemental Content

Loading ...
Support Center